Parsatuzumab
From Infogalactic: the planetary knowledge core
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | EGFL7 |
Identifiers | |
CAS Number | 1312797-14-0 |
ATC code | none |
Chemical data | |
Formula | C6560H10130N1758O2046S46 |
Molecular mass | 147.8 kg/mol |
Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.[1]
This drug was developed by Genentech/Roche.[2]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Parsatuzumab, American Medical Association.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibodies for tumors
- Monoclonal antibody stubs